Perdriger A, Guggenbuhl P, Chalès G, Yaouanq J, Quelvennec E, Bonnard M N, Pawlotsky Y, Semana G
Department of Rheumatology, Teaching Hospital, Rennes, France.
Rheumatology (Oxford). 1999 May;38(5):448-52. doi: 10.1093/rheumatology/38.5.448.
HLA DM is a non-classical major histocompatibility complex (MHC) class II molecule that has been shown to facilitate peptide loading with classical class II molecules.
In this study, we analysed the polymorphism in exon 3 of HLA DMA and DMB genes by a polymerase chain reaction-sequence-specific oligonucleotide probe method in 163 rheumatoid arthritis (RA) patients and 146 ethnically matched controls. The HLA-DRB1 genotype was also analysed by a reverse-dot blot method.
Our results show in RA patients a significant increase in the HLA DMB0101 allele frequency (83% vs 72.3% of the controls, P < 1.6 x 10(-3), significance at P < 0.0125) and in the HLA DMB0101-0101 homozygote genotype frequency [70.8% vs 50% of the controls, P < 4.2 x 10(-4), significance at P < 0.00625, odds ratio (OR) = 2.4, 95% confidence interval (CI): 1.43-4]. The increase in DMB0101 allele and homozygote genotype frequencies was independent of a linkage disequilibrium between DMB and DRB1 alleles. The analysis of non-random associations between the HLA-DM and DRB1 alleles only revealed a significant association in controls between DMB0104 and DRB107 alleles (delta = 0.01, P < 7 x 10(-4), significance at P < 9.6 x 10(-4)). On the other hand, the DMB0101-0102 genotype frequency was increased in DRB1*0401-negative RA patients as compared to controls (11% vs 2%, P < 0.011, significance at P < 0.015, OR = 6.2, 95% CI: 1.2-30).
Our data suggest that HLA-DM alleles could play a role in the genetic susceptibility to RA.
HLA DM是一种非经典的主要组织相容性复合体(MHC)II类分子,已被证明可促进经典II类分子的肽负载。
在本研究中,我们采用聚合酶链反应-序列特异性寡核苷酸探针法,对163例类风湿关节炎(RA)患者和146例种族匹配的对照者的HLA DMA和DMB基因外显子3的多态性进行了分析。还采用反向斑点杂交法分析了HLA-DRB1基因型。
我们的结果显示,RA患者中HLA DMB0101等位基因频率显著增加(83%对对照组的72.3%,P < 1.6 x 10(-3),在P < 0.0125时有显著性),HLA DMB0101-0101纯合子基因型频率也增加[70.8%对对照组的50%,P < 4.2 x 10(-4),在P < 0.00625时有显著性,优势比(OR)= 2.4,95%置信区间(CI):1.43 - 4]。DMB0101等位基因和纯合子基因型频率的增加与DMB和DRB1等位基因之间的连锁不平衡无关。HLA-DM和DRB1等位基因之间的非随机关联分析仅显示,在对照组中DMB0104和DRB107等位基因之间存在显著关联(δ = 0.01,P < 7 x 10(-4),在P < 9.6 x 10(-4)时有显著性)。另一方面,与对照组相比,DRB10401阴性的RA患者中DMB*0101-0102基因型频率增加(11%对2%,P < 0.011,在P < 0.015时有显著性,OR = 6.2,95% CI:1.2 - 30)。
我们的数据表明,HLA-DM等位基因可能在RA的遗传易感性中起作用。